Warning: mysql_query() [function.mysql-query]: Unable to save result set in /www/users/HK591466/WEB/includes/db.inc.php on line 59
Database error: Invalid SQL: select * from pwn_comment where pid='908078' and iffb='1' order by id limit 0,10
MySQL Error: 996 (Query execution was interrupted, max_statement_time exceeded)
#0 dbbase_sql->halt(Invalid SQL: select * from pwn_comment where pid='908078' and iffb='1' order by id limit 0,10) called at [/www/users/HK591466/WEB/includes/db.inc.php:65] #1 dbbase_sql->query(select * from {P}_comment where pid='908078' and iffb='1' order by id limit 0,10) called at [/www/users/HK591466/WEB/comment/module/CommentContent.php:167] #2 CommentContent() called at [/www/users/HK591466/WEB/includes/common.inc.php:551] #3 printpage() called at [/www/users/HK591466/WEB/comment/html/index.php:13]
Warning: mysql_fetch_array(): supplied argument is not a valid MySQL result resource in /www/users/HK591466/WEB/includes/db.inc.php on line 72
网友点评-In PMC 2009 November 10.Printed <a href="https://www.ncbi.nlm.nih.-缅甸银河国际-13150768882
您好,欢迎光临!   [请登录]   [免费注册]
发布于:2019-8-15 14:54:56  访问:78 次 回复:0 篇
版主管理 | 推荐 | 删除 | 删除并扣分
In PMC 2009 November 10.Printed <a href="https://www.ncbi.nlm.nih.
doi:10.1097/01.HCO.0000013803.40803.6A.NIH-PA Creator Manuscript NIH-PA Writer Manuscript NIH-PA Creator ManuscriptIPI-926 In Vivo modifier genes for hypertrophic cardiomyopathyA. In general, causal mutations account for just a portion with the variability of phenotypes and genetic track record, known as the modifier genes, participate in a significant function. The ultimate phenotype will be the consequence of interactions in between the causal genes, genetic qualifications (modifier genes), and probably the environmental variables. The person modifier genes for HCM continue being largely mysterious, and a large-scale genome-wide solution and candidate gene analysis are needed. Present reports are confined to simple polymorphism association research, which examine the affiliation of functional single nucleotide polymorphisms in genes implicated in cardiac advancement while using the severity in the medical phenotypes, mainly cardiac hypertrophy. Quite a few probable modifier genes which include genes encoding the factors of your reninangiotensin-aldosterone technique have emerged. By far the most usually implicated is definitely an insertion/ deletion polymorphism from the angiotensin-1 changing enzyme 1 gene, and that is involved along with the danger of unexpected cardiac loss of life and also the severity of hypertrophy. Therapeutic interventions directed at concentrating on the modifier genes have shown salutary consequences in animal styles of HCM. It has now recognized that modifier genes have an affect on the expression of cardiac phenotype. Identification of your modifier genes will enhance the final results of studies of causative genes and could increase genetic based prognosis, risk stratification, and implementation of preventive and therapeutic actions in people with HCM. The phenotype of single gene diseases, significantly autosomal dominant conditions, is affected by genetic factors aside from the causal mutation. Genetic background, sometimes called the modifier genes, is thought to have an effect on the phenotypic expression of monogenic ailments, these types of as hypertrophic cardiomyopathy (HCM). Modifier genes never result in the condition but basically affect the severity of its phenotypic expression. This is certainly especially so with autosomal dominant ailments by which age-dependent onset and variable expressivity are characteristic. While in the circumstance of HCM, mutations in contractile sarcomeric proteins are needed to trigger HCM; however, the contribution of the causal mutations to the severity of phenotype may be rather modest, along with the modifier genes (genetic history) enjoying a significant purpose. It is now recognized that even though the phenotype of any single gene problem predominantly determined with the causal mutation, it really is also markedly influenced by its interactions with other modifying genes and the surroundings.In PMC 2009 November 10.Published PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/22960595 in ultimate edited kind as: Curr Opin Cardiol. 2002 Might ; seventeen(3): 242?fifty two. doi:ten.1097/01.HCO.0000013803.40803.6A.NIH-PA Author Manuscript NIH-PA Writer Manuscript NIH-PA Creator ManuscriptModifier genes for hypertrophic cardiomyopathyA. J. Marian, MD PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/24741339 Segment of Cardiology, Division of medication, Baylor College or university of medicine, Houston, Texas, United states.AbstractDuring the past decade, a lot more than a hundred mutations in eleven causal gene coding for sarcomeric proteins, the subunit of AMP-activated protein kinase and triplet-repeat syndromes and in mitochondrial DNA, have been recognized in patients with hypertrophic cardiomyopathy (HCM).
共0篇回复 每页10篇 页次:1/1
共0篇回复 每页10篇 页次:1/1
验 证 码